NLRP3 - NLR family pyrin domain containing 3 Gene
Species: Felis catus
Gene Type: protein coding
Gene ID: 101092579
NLRP3 Products (2)
| mRNA | Protein | Name |
|---|---|---|
| XM_045056515.1 | XP_044912450.1 | NACHT, LRR and PYD domains-containing protein 3 isoform X2 |
| XM_023253644.2 | XP_023109412.2 | NACHT, LRR and PYD domains-containing protein 3 isoform X1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
NACHT, LRR and PYD domains-containing protein 3 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(13)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B2176 | ATP | Activator | 99.88% | Unkown |
| HY-132591A | Inclisiran sodium | Inhibitor | 99.08% | Unkown |
| HY-132591 | Inclisiran | Inhibitor | 99.48% | Unkown |
| HY-B0116 | Stavudine | Inhibitor | 99.89% | Yes |
| HY-14806B | Teneligliptin hydrobromide hydrate | Inhibitor | 99.97% | Unkown |
| HY-16059 | Arglabin | Inhibitor | 99.87% | Unkown |
| HY-B1239 | Drofenine hydrochloride | 98.10% | Unkown | |
| HY-17355B | Dexpramipexole | Inhibitor | 99.56% | Yes |
| HY-B0516 | Articaine hydrochloride | Inhibitor | 99.38% | Unkown |
| HY-B1239A | Drofenine | / | Unkown | |
| HY-B0516A | Articaine | Inhibitor | / | Unkown |
| HY-B0516R | Articaine hydrochloride (Standard) | Inhibitor | / | Unkown |
| HY-B0116A | Stavudine sodium | Inhibitor | 99.40% | Yes |
Clinical Phase
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-156034A | JT001 sodium | Inhibitor | 98.39% | Phase 3 |
| HY-156034 | JT001 | Inhibitor | / | Phase 3 |
| HY-P10227 | Xelafaslatide | Inhibitor | 99.88% | Phase 2 |
| HY-139396 | BMS-986299 | Agonist | 99.96% | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99555 | Tomaralimab | Inhibitor | 99.42% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(166)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-12815 | MCC950 | Inhibitor | 99.78% | Unkown |
| HY-127019 | Nigericin | Activator | 99.64% | Unkown |
| HY-100381 | Nigericin sodium salt | Activator | 99.60% | Unkown |
| HY-12815A | MCC950 sodium | Inhibitor | 99.75% | Unkown |
| HY-100573 | Necrosulfonamide | Inhibitor | 98.61% | Unkown |
| HY-116084 | Trimethylamine N-oxide | Activator | 98.0% | Unkown |
| HY-103666 | CY-09 | Inhibitor | 99.58% | Unkown |
| HY-144226 | NLRP3/AIM2-IN-3 | Inhibitor | 98.23% | Unkown |
| HY-17629 | Dapansutrile | Inhibitor | 99.92% | Yes |
| HY-101092 | QS-21-Api | Activator | 99.73% | Unkown |
| HY-156798 | ADS032 | Inhibitor | 99.89% | Unkown |
| HY-113298 | Citraconic acid | Inhibitor | 99.08% | Unkown |
| HY-N0373 | Licochalcone B | Inhibitor | 99.91% | Unkown |
| HY-N3005 | Britannin | Inhibitor | 99.93% | Unkown |
| HY-108915 | Trimethylamine N-oxide dihydrate | Activator | 99.86% | Unkown |
| HY-N0633 | Muscone | Inhibitor | 98.0% | Unkown |
| HY-100581 | CORM-3 | Inhibitor | 97.5% | Unkown |
| HY-155876 | NVP-DFV890 | Antagonist | 99.97% | Unkown |
| HY-N0806 | Sweroside | Inhibitor | 99.76% | Unkown |
| HY-N0496 | Ruscogenin | Inhibitor | 99.85% | Unkown |
| HY-132831 | Selnoflast | Inhibitor | 99.46% | Unkown |
| HY-W019670 | N4-Acetylcytidine | Activator | 99.65% | Unkown |
| HY-N2414 | Periplogenin | Inhibitor | ≥99.70% | Unkown |
| HY-161834 | RG100204 | Inhibitor | 99.50% | Unkown |
| HY-N5042 | Forsythoside I | Inhibitor | 99.94% | Unkown |
| HY-159520 | Ofirnoflastum | Inhibitor | 99.93% | Unkown |
| HY-N5063 | Plantainoside D | Inhibitor | 99.15% | Unkown |
| HY-169996 | NP3-253 | Inhibitor | 99.78% | Unkown |
| HY-173154B | NK7-902 diTFA | Inhibitor | 99.88% | Unkown |
| HY-162333 | BAL-0028 | Inhibitor | 99.86% | Unkown |
| HY-130494 | (±)11(12)-EET | Inhibitor | 98.30% | Unkown |
| HY-N0257 | Epimedin A | Inhibitor | 99.43% | Unkown |
| HY-152670 | JC2-11 | Inhibitor | 98.03% | Unkown |
| HY-119684 | Maresin 2 | Inhibitor | 97.20% | Unkown |
| HY-78263 | MNS | 99.55% | Unkown | |
| HY-W082785A | L6H21 | Inhibitor | 99.19% | Unkown |
| HY-N1939 | Icariside I | Agonist | 98.76% | Unkown |
| HY-B2176I | ATP disodium salt, 100 mM Solution, PCR Grade | Activator | / | Unkown |
| HY-N0381 | Maackiain | Activator | 99.83% | Unkown |
| HY-N1431 | Tabersonine | Inhibitor | 98.13% | Unkown |
| HY-137888A | Oxidized ATP trisodium salt | Inhibitor | 98.0% | Unkown |
| HY-117878 | ML345 | Inhibitor | 99.37% | Unkown |
| HY-144223 | NLRP3-IN-94 | Inhibitor | 99.93% | Unkown |
| HY-164304 | INF 195 | Inhibitor | 99.58% | Unkown |
| HY-P2310 | Defensin HNP-1 human | Activator | 98.12% | Unkown |
| HY-N6893 | Ergolide | Inhibitor | 99.48% | Unkown |
| HY-150206 | NLRP3-IN-13 | Inhibitor | 98.03% | Unkown |
| HY-N3242 | Moronic acid | Inhibitor | 98.6% | Unkown |
| HY-101868 | INF39 | Inhibitor | 99.84% | Unkown |
| HY-153261 | NLRP3-IN-17 | Inhibitor | 99.02% | Unkown |
| HY-120007 | JC124 | Inhibitor | 99.72% | Unkown |
| HY-163358 | SLC3037 | Inhibitor | 99.85% | Unkown |
| HY-W158030 | 2-Guanidinobezimidazole | Agonist | 95.74% | Unkown |
| HY-N0699 | Daphnoretin | Inhibitor | 99.83% | Unkown |
| HY-N2485 | 4'-Methoxyresveratrol | Activator | 99.48% | Unkown |
| HY-176860 | NEK7 degrader-1 | Activator | 99.94% | Unkown |
| HY-163159 | NP3-562 | Inhibitor | 98.16% | Unkown |
| HY-130252 | YQ128 | Inhibitor | 99.74% | Unkown |
| HY-N2128 | Nigakinone | Inhibitor | 99.95% | Unkown |
| HY-137245 | Emlenoflast | Inhibitor | 99.30% | Unkown |
| HY-N2157 | Pteryxin | Inhibitor | 99.55% | Unkown |
| HY-N7695 | Physalin B | Inhibitor | 97.20% | Unkown |
| HY-155751 | HMGB1-IN-1 | Inhibitor | 98.40% | Unkown |
| HY-160757 | NLRP3 modulator 7 | Modulator | / | Unkown |
| HY-146765 | AMS-17 | Inhibitor | 98.09% | Unkown |
| HY-179494 | M464 | Inhibitor | 99.58% | Unkown |
| HY-N8599 | Cichoriin | Inhibitor | 99.9% | Unkown |
| HY-161727 | P2Y14R antagonist 1 | Inhibitor | 98.76% | Unkown |
| HY-172941 | VEN-02XX | Inhibitor | 99.66% | Unkown |
| HY-122920 | Soyasaponin II | Inhibitor | 99.81% | Unkown |
| HY-126941 | Hecogenin acetate | Inhibitor | 98.57% | Unkown |
| HY-164853 | Kanglexin | Inhibitor | 99.65% | Unkown |
| HY-175278 | BAL-1516 | Inhibitor | / | Unkown |
| HY-161627 | Anemoside A3-methyl 6-aminohexanoate | Inhibitor | 98.62% | Unkown |
| HY-174270 | NLRP3-IN-79 | Inhibitor | 99.10% | Unkown |
| HY-W011082 | NLRP3-IN-2 | Inhibitor | 98.00% | Unkown |
| HY-137245A | Emlenoflast sodium | Inhibitor | 98.31% | Unkown |
| HY-117432 | JC-171 | Inhibitor | 98.06% | Unkown |
| HY-W017087 | 1,2,4-Trimethoxybenzene | Inhibitor | / | Unkown |
| HY-186072 | NT-0527 | Inhibitor | 99.80% | Unkown |
| HY-131040 | NLRP3-IN-NBC6 | Inhibitor | 99.40% | Unkown |
| HY-162588 | MC-ND-18 | Degrader | / | Unkown |
| HY-161297 | NT-0249 | Inhibitor | / | Unkown |
| HY-153554 | NLRP3-IN-18 | Inhibitor | 98.06% | Unkown |
| HY-121988 | INF4E | Inhibitor | 99.38% | Unkown |
| HY-148187 | NLRP3-IN-11 | Inhibitor | 98.79% | Unkown |
| HY-P6084 | RP-220 | Inhibitor | / | Unkown |
| HY-179421 | PROTAC HDAC6 degrader 7 | Inhibitor | / | Unkown |
| HY-145087A | NP3-146 sodium | Inhibitor | 99.26% | Unkown |
| HY-W010253 | Benzylurea | Modulator | 99.94% | Unkown |
| HY-N10173 | (+)-Epiloliolide | Inhibitor | 95.0% | Unkown |
| HY-N10359 | Isoandrographolide | Inhibitor | 98.34% | Unkown |
| HY-150965 | NDT-30805 | Inhibitor | / | Unkown |
| HY-146594 | NLRP3-IN-8 | Inhibitor | / | Unkown |
| HY-179429 | NLRP3-IN-85 | Inhibitor | / | Unkown |
| HY-178898 | 7-Oxogedunin | Inhibitor | / | Unkown |
| HY-183283 | CAII-IN-15 | Inhibitor | / | Unkown |
| HY-149123 | NLRP3-IN-16 | Inhibitor | / | Unkown |
| HY-180830 | NLRP3-IN-86 | Inhibitor | / | Unkown |
| HY-145087 | NP3-146 | Inhibitor | / | Unkown |
| HY-182779 | JNUTS013 | Inhibitor | / | Unkown |
| HY-179024 | NP3-742 | Inhibitor | / | Unkown |
| HY-175464 | NLRP3-IN-82 | Inhibitor | / | Unkown |
| HY-175814 | NLRP3-IN-83 | Inhibitor | / | Unkown |
| HY-183995 | SH-26 | Inhibitor | / | Unkown |
| HY-182803 | NLRP3-IN-90 | Inhibitor | / | Unkown |
| HY-179387 | CXCR2-IN-3 | Inhibitor | / | Unkown |
| HY-159482 | SBN-284 | Inhibitor | / | Unkown |
| HY-163744 | NLRP3-IN-42 | Inhibitor | / | Unkown |
| HY-168264 | MC1 | Inhibitor | / | Unkown |
| HY-P11581 | MNP2 | Inhibitor | / | Unkown |
| HY-180168 | NQO2 activator-1 | Inhibitor | / | Unkown |
| HY-182102 | NLRP3-IN-88 | Inhibitor | / | Unkown |
| HY-146802 | NLRP3-IN-9 | Inhibitor | / | Unkown |
| HY-168737 | NEK7-IN-2 | Inhibitor | / | Unkown |
| HY-179131 | TN-783 | Inhibitor | / | Unkown |
| HY-180916 | CAII-IN-11 | Inhibitor | / | Unkown |
| HY-N19847 | LYRM03 | Inhibitor | / | Unkown |
| HY-168009 | NLRP3-IN-45 | Inhibitor | / | Unkown |
| HY-N10312 | Yadanzigan | Inhibitor | / | Unkown |
| HY-132831C | Selnoflast monopotassium | Inhibitor | / | Unkown |
| HY-177559 | NEK7 degrader-2 | Inhibitor | / | Unkown |
| HY-181809 | BLT1-IN-1 | Inhibitor | / | Unkown |
| HY-132892 | NLRP3-IN-4 | Inhibitor | / | Unkown |
| HY-N10650 | Caulerpin | Inhibitor | / | Unkown |
| HY-178953 | NLRP3-IN-84 | Inhibitor | / | Unkown |
| HY-172134 | NLRP3-IN-70 | Inhibitor | / | Unkown |
| HY-182778 | Anti-inflammatory agent 114 | Inhibitor | / | Unkown |
| HY-149122 | NLRP3-IN-15 | Inhibitor | / | Unkown |
| HY-178950 | Hck-IN-3 | Inhibitor | / | Unkown |
| HY-171589 | NLRP3-IN-77 | Inhibitor | / | Unkown |
| HY-172778 | HNW005 | Inhibitor | / | Unkown |
| HY-149121 | NLRP3-IN-14 | Inhibitor | / | Unkown |
| HY-184357 | NLRP3-IN-92 | Inhibitor | / | Unkown |
| HY-182380 | ODZ10117 | Inhibitor | / | Unkown |
| HY-181488 | NLRP3-IN-87 | Inhibitor | / | Unkown |
| HY-163497 | NLRP3-IN-38 | Inhibitor | / | Unkown |
| HY-169227 | NLRP3-IN-55 | Inhibitor | / | Unkown |
| HY-177128 | Sebrinoflast | Inhibitor | / | Unkown |
| HY-174312 | NLRP3-IN-81 | Inhibitor | / | Unkown |
| HY-183296 | NLRP3-IN-91 | Inhibitor | / | Unkown |
| HY-185311 | NEK7 degrader-3 | Inhibitor | / | Unkown |
| HY-172102 | NLRP3-IN-68 | Inhibitor | / | Unkown |
| HY-175645 | NLRP3/URAT1-IN-1 | Inhibitor | / | Unkown |
| HY-163494 | NLRP3-IN-36 | Inhibitor | / | Unkown |
| HY-168594 | α-Glucosidase/NLRP3-IN-1 | Inhibitor | / | Unkown |
| HY-180890 | PPARγ agonist-21 | Inhibitor | / | Unkown |
| HY-149087 | MR2938 | Inhibitor | / | Unkown |
| HY-169188 | NLRP3-IN-50 | Inhibitor | / | Unkown |
| HY-159898 | AChE/BChE-IN-23 | Inhibitor | / | Unkown |
| HY-179132 | TN-101 | Inhibitor | / | Unkown |
| HY-145910 | NLRP3-IN-6 | Inhibitor | / | Unkown |
| HY-161329 | NLRP3-IN-32 | Inhibitor | / | Unkown |
| HY-183796 | GFAP/NF-κB/APOE/NLRP3-IN-1 | Inhibitor | / | Unkown |
| HY-179682 | HDAC3 degrader-1 | Inhibitor | / | Unkown |
| HY-N6189 | MBL-1 | Inhibitor | / | Unkown |
| HY-163695 | NLRP3-IN-41 | Inhibitor | / | Unkown |
| HY-103715 | NLRP3 modulator 1 | Modulator | / | Unkown |
| HY-145911 | NLRP3-IN-7 | Inhibitor | / | Unkown |
| HY-182794 | NLRP3-IN-89 | Inhibitor | / | Unkown |
| HY-N17383 | Ligusticum cycloprolactam | Inhibitor | / | Unkown |
| HY-182287 | PRDX1-IN-4 | Inhibitor | / | Unkown |
| HY-159007 | BD-AcAc2 | Inhibitor | / | Unkown |
| HY-173294 | NLRP3-IN-74 | Inhibitor | / | Unkown |
| HY-N1431A | Tabersonine hydrochloride | Inhibitor | 98.55% | Unkown |
| HY-183889 | p-Ethoxychrysoidin | Inhibitor | / | Unkown |
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Homo sapiens | NLRP3 | NCBI | NCBI:114548 |
| Mus musculus | NLRP3 | NCBI | NCBI:216799 |